Predictive markers for ovarian cancer
First Claim
Patent Images
1. A set of reagents to measure the levels of biomarkers in a specimen, wherein the biomarkers are selected from the group consisting of the following panels of biomarkers or measurable fragments thereof:
- (a) myoglobin, CRP, FGF basic protein and CA 19-9;
(b) Hepatitis C NS4, Ribosomal P Antibody and CRP;
(c) CA 19-9, TGF alpha, EN-RAGE, EGF and HSP 90 alpha antibody,(d) EN-RAGE, EGF, CA 125, Fibrinogen, Apolipoprotein CIII, Cholera Toxin and CA 19-9;
(e) Proteinase 3 (cANCA) antibody, Fibrinogen, CA 125, EGF, CD40, TSH, Leptin, CA 19-9 and lymphotactin;
(f) CA125, EGFR, CRP, IL-18, Apolipoprotein CIII, Tenascin C and Apolipoprotein A1;
(g) CA125, Beta-2 Microglobulin, CRP, Ferritin, TIMP-1, Creatine Kinase-MB and IL-8;
(h) CA125, EGFR, IL-10, Haptoglobin, CRP, Insulin, TIMP-1, Ferritin, Alpha-2 Macroglobulin, Leptin, IL-8, CTGF, EN-RAGE, Lymphotactin, TNF-alpha, IGF-1, TNF RII, von Willebrand Factor and MDC;
(i) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-18 and VCAM-1;
j) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and VCAM-1;
(k) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, IL-6 and MIP-1;
(1) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and vWF;
(m) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and IL-18;
(n) CA-125, CRP, EGF-R, CA-19-9, Apo A1, MIP-1 and vWF;
(o) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, Apo A1, and MIP-1;
(p) CA-125, CRP, EGF-R, IL-6, myoglobin, MIP-1 and myeloperoxidase;
(q) CA-125, CRP, EGF-R, CA-19-9, myoglobin MIP-1 and Growth Hormone;
(r) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and myeloperoxidase;
(s) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and IL-18;
(t) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Growth Hormone and VCAM-1;
(u) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and Leptin;
(v) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and Growth Hormone;
(w) CA-125, CRP, EGF-R, CA-19-9, IL-6, myoglobin and Growth Hormone;
(x) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and myeloperoxidase;
(y) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and insulin;
(z) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and ferritin;
(aa) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and myeloperoxidase;
(bb) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, myoglobin, and MIP-1;
(cc) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and haptoglobulin;
(dd) CA-125, CRP, EGF-R, CA-19-9, ApoA1, myoglobin, MIP-1 and leptin;
(ee) CA-125, CRP, EGF-R, CA-19-9, IL-6, vWF and ApoCIII;
(ff) CA-125, CRP, EGF-R, Serum Amyloid P, IL-6, MIP-1 and ferritin;
(gg) CA-125, CRP, EGF-R, CA-19-9, vWF, ApoCIII and ferritin;
(hh) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and ferritin;
(ii) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and ApoCIII;
(jj) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and ferritin;
(kk) CA-125, CRP, EGF-R, CA-19-9, IL-6, CK-MB and vWF; and
(ll) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-10 and ferritin.
4 Assignments
0 Petitions
Accused Products
Abstract
Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided.
-
Citations
20 Claims
-
1. A set of reagents to measure the levels of biomarkers in a specimen, wherein the biomarkers are selected from the group consisting of the following panels of biomarkers or measurable fragments thereof:
-
(a) myoglobin, CRP, FGF basic protein and CA 19-9; (b) Hepatitis C NS4, Ribosomal P Antibody and CRP; (c) CA 19-9, TGF alpha, EN-RAGE, EGF and HSP 90 alpha antibody, (d) EN-RAGE, EGF, CA 125, Fibrinogen, Apolipoprotein CIII, Cholera Toxin and CA 19-9; (e) Proteinase 3 (cANCA) antibody, Fibrinogen, CA 125, EGF, CD40, TSH, Leptin, CA 19-9 and lymphotactin; (f) CA125, EGFR, CRP, IL-18, Apolipoprotein CIII, Tenascin C and Apolipoprotein A1; (g) CA125, Beta-2 Microglobulin, CRP, Ferritin, TIMP-1, Creatine Kinase-MB and IL-8; (h) CA125, EGFR, IL-10, Haptoglobin, CRP, Insulin, TIMP-1, Ferritin, Alpha-2 Macroglobulin, Leptin, IL-8, CTGF, EN-RAGE, Lymphotactin, TNF-alpha, IGF-1, TNF RII, von Willebrand Factor and MDC; (i) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-18 and VCAM-1; j) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and VCAM-1; (k) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, IL-6 and MIP-1; (1) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and vWF; (m) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and IL-18; (n) CA-125, CRP, EGF-R, CA-19-9, Apo A1, MIP-1 and vWF; (o) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, Apo A1, and MIP-1; (p) CA-125, CRP, EGF-R, IL-6, myoglobin, MIP-1 and myeloperoxidase; (q) CA-125, CRP, EGF-R, CA-19-9, myoglobin MIP-1 and Growth Hormone; (r) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and myeloperoxidase; (s) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and IL-18; (t) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Growth Hormone and VCAM-1; (u) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and Leptin; (v) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and Growth Hormone; (w) CA-125, CRP, EGF-R, CA-19-9, IL-6, myoglobin and Growth Hormone; (x) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and myeloperoxidase; (y) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and insulin; (z) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and ferritin; (aa) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and myeloperoxidase; (bb) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, myoglobin, and MIP-1; (cc) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and haptoglobulin; (dd) CA-125, CRP, EGF-R, CA-19-9, ApoA1, myoglobin, MIP-1 and leptin; (ee) CA-125, CRP, EGF-R, CA-19-9, IL-6, vWF and ApoCIII; (ff) CA-125, CRP, EGF-R, Serum Amyloid P, IL-6, MIP-1 and ferritin; (gg) CA-125, CRP, EGF-R, CA-19-9, vWF, ApoCIII and ferritin; (hh) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and ferritin; (ii) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and ApoCIII; (jj) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and ferritin; (kk) CA-125, CRP, EGF-R, CA-19-9, IL-6, CK-MB and vWF; and (ll) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-10 and ferritin. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A set of antibodies fixed to a microsphere to measure the levels of biomarkers in a specimen, wherein the biomarkers are selected from the group consisting of the following panels of biomarkers and their measurable fragments:
-
(a) myoglobin, CRP, FGF basic protein and CA 19-9; (b) Hepatitis C NS4, Ribosomal P Antibody and CRP; (c) CA 19-9, TGF alpha, EN-RAGE, EGF and HSP 90 alpha antibody; (d) EN-RAGE, EGF, CA 125, Fibrinogen, Apolipoprotein CIII, Cholera Toxin and CA 19-9; (e) Proteinase 3 (cANCA) antibody, Fibrinogen, CA 125, EGF, CD40, TSH, Leptin, CA 19-9 and lymphotactin; (f) CA125, EGFR, CRP, IL-18, Apolipoprotein CIII, Tenascin C and Apolipoprotein A1; (g) CA125, Beta-2 Microglobulin, CRP, Ferritin, TIMP-1, Creatine Kinase-MB and IL-8; (h) CA125, EGFR, IL-10, Haptoglobin, CRP, Insulin, TIMP-1, Ferritin, Alpha-2 Macroglobulin, Leptin, IL-8, CTGF, EN-RAGE, Lymphotactin, TNF-alpha, IGF-1, TNF RII, von Willebrand Factor and MDC; (i) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-18 and VCAM-1; (j) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and VCAM-1; (k) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, IL-6 and MIP-1; (l) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and vWF; (m) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and IL-18; (n) CA-125, CRP, EGF-R, CA-19-9, Apo A1, MIP-1 and vWF; (o) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, Apo A1, and MIP-1; (p) CA-125, CRP, EGF-R, IL-6, myoglobin, MIP-1 and myeloperoxidase; (q) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and Growth Hormone; (r) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and myeloperoxidase; (s) CA-125, CRP, EGF-R, CA-19-9, MIP-1, Growth Hormone and IL-18; (t) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Growth Hormone and VCAM-1; (u) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and Leptin; (v) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and Growth Hormone; (w) CA-125, CRP, EGF-R, CA-19-9, IL-6, myoglobin and Growth Hormone; (x) CA-125, CRP, EGF-R, CA-19-9, myoglobin, Leptin and myeloperoxidase; (y) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and insulin; (z) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and ferritin; (aa) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and myeloperoxidase; (bb) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, myoglobin, and MIP-1; (cc) CA-125, CRP, EGF-R, CA-19-9, myoglobin, MIP-1 and haptoglobulin; (dd) CA-125, CRP, EGF-R, CA-19-9, ApoA1, myoglobin, MIP-1 and leptin; (ee) CA-125, CRP, EGF-R, CA-19-9, IL-6, vWF and ApoCIII; (ff) CA-125, CRP, EGF-R, Serum Amyloid P, IL-6, MIP-1 and ferritin; (gg) CA-125, CRP, EGF-R, CA-19-9, vWF, ApoCIII and ferritin; (hh) CA-125, CRP, EGF-R, CA-19-9, IL-6, MIP-1 and ferritin; (ii) CA-125, CRP, EGF-R, CA-19-9, MIP-1, vWF and ApoCIII; (jj) CA-125, CRP, EGF-R, CA-19-9, Serum Amyloid P, ApoCIII and ferritin; (kk) CA-125, CRP, EGF-R, CA-19-9, IL-6, CK-MB and vWF; and (ll) CA-125, CRP, EGF-R, CA-19-9, MIP-1, IL-10 and ferritin.
-
Specification